Chief Medical Officer Paul Kelly has responded to concerns over the Oxford-AstraZeneca COVID-19 vaccine arguing that once regulators approve the vaccine, Australia will be a prime position to achieve herd immunity. Some of Australia’s medical community have raised concerns that the AstraZeneca vaccine does not meet the efficacy standards to effectively counter the CCP virus citing a report published in The Lancet in December 2020 that said the vaccine efficacy ranged from 62 to 90 percent. Kelly noted that the Australian government was collecting more data beyond the Lancet report and that the Therapeutic Goods Administration was giving it a thorough assessment. “We’ve had three more months of data that will be available to the TGA, and more data from the real-world information that’s coming from the UK, in particular, who are already rolling out that vaccine. So, we’ll look at that, we’ll wait for that,” Kelly told ABC News Breakfast on …